deCODE Genetics Study Finds Father’s Age Critical to New Mutations Passed to Offspring
News Aug 24, 2012
deCODE Genetics in collaboration with Illumina has reported in the journal Nature that a father’s age, not a mother’s, at the time a child is conceived is the single largest contributor to the passing of new hereditary mutations to offspring.
The findings come from the largest whole genome sequencing project to examine associations of diseases with rare variants in the genome.
“Strikingly, this study found that a father’s age at the time a child is conceived explains nearly all of the population diversity in new hereditary mutations found in the offspring,” said study lead author Kari Stefansson, M.D., Dr. Med., CEO of deCODE Genetics.
Stefansson continued, “With the results here, it is now clear that demographic transitions that affect the age at which males reproduce can have a considerable impact on the rate of certain diseases linked to new mutation.”
To better understand the cause of new hereditary mutations, the deCODE team sequenced the genomes of 78 Icelandic families with offspring who had a diagnosis of autism or schizophrenia.
The team also sequenced the genomes of an additional 1,859 Icelanders, providing a larger comparative population.
On average, the investigators found a two mutation per-year increase in offspring with each one-year increase in age of the father.
The average age of the father in the study was 29.7 years old. Also, when specifically examining the genomes of families with autism and schizophrenia, the authors identified in offspring mutations in genes previously implicated in the diseases.
They also identified two genes, CUL3 and EPHB2, with mutations in an autism patient subgroup.
“Our results all point to the possibility that as a man ages, the number of hereditary mutations in his sperm increases, and the chance that a child would carry a deleterious mutation that could lead to diseases such as autism and schizophrenia increases proportionally,” said Dr. Stefansson.
Dr. Stefansson continued, “It is of interest here that conventional wisdom has been to blame developmental disorders of children on the age of mothers, whereas the only problems that come with advancing age of mothers is a risk of Down syndrome and other rare chromosomal abnormalities. It is the age of fathers that appears to be the real culprit.”
Epidemiological studies in Iceland show the risk of both schizophrenia and autism spectrum disorders increases significantly with father’s age at conception, and that the average age of father’s in Iceland (now 33 years-old) at the time a child is conceived is on the rise.
The authors noted that demographic change of this kind and magnitude is not unique to Iceland, and it raises the question of whether the reported increase in autism spectrum disorder diagnosis is at least partially due to an increase in the average age of fathers at conception.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.